{"id":"https://openalex.org/W120022667","doi":null,"title":"Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?","display_name":"Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?","publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W120022667","mag":"120022667","pmid":"https://pubmed.ncbi.nlm.nih.gov/18506123"},"language":"en","primary_location":{"id":"pmid:18506123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18506123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International angiology : a journal of the International Union of Angiology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007859032","display_name":"Jawed Fareed","orcid":"https://orcid.org/0000-0003-3465-2499","observed_orcids":["https://orcid.org/0000-0003-3465-2499"]},"institutions":[{"id":"https://openalex.org/I1304196042","display_name":"Loyola University Medical Center","ror":"https://ror.org/05xcyt367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304196042","https://openalex.org/I1304269903"]},{"id":"https://openalex.org/I4210159390","display_name":"Loyola Medicine","ror":"https://ror.org/04azs9g49","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210159390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J Fareed","raw_affiliation_strings":["Hemostasis and Thrombosis Research Laboratoires, Loyola University Medical Center, Maywood, IL, USA. jfareed@lumc.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hemostasis and Thrombosis Research Laboratoires, Loyola University Medical Center, Maywood, IL, USA. jfareed@lumc.edu","institution_ids":["https://openalex.org/I1304196042","https://openalex.org/I4210159390"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034121067","display_name":"Omer Iqbal","orcid":"https://orcid.org/0000-0002-0791-6957","observed_orcids":["https://orcid.org/0000-0002-0791-6957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Iqbal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109841490","display_name":"J. Cunanan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Cunanan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103083288","display_name":"M. Demir","orcid":"https://orcid.org/0000-0003-4961-4639","observed_orcids":["https://orcid.org/0000-0003-4961-4639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Demir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001223444","display_name":"Rakesh Wahi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Wahi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Clarke","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Clarke","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008911553","display_name":"Cafer Ad\u0131g\u00fczel","orcid":"https://orcid.org/0009-0004-1437-1969","observed_orcids":["https://orcid.org/0009-0004-1437-1969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Adiguzel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112235155","display_name":"Roger L. Bick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Bick","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8506,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.74964567,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"27","issue":"3","first_page":"176","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9286999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.06289999932050705,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticoagulation","display_name":"anticoagulation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.8539999723434448},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.9330000281333923},{"id":"https://openalex.org/keywords/oral-anticoagulants","display_name":"oral anticoagulants","score":0.9700000286102295},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.847000002861023},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.7730000019073486},{"id":"https://openalex.org/keywords/antiplatelet-drugs","display_name":"antiplatelet agents","score":0.871999979019165},{"id":"https://openalex.org/keywords/ximelagatran","display_name":"ximelagatran","score":0.8479999899864197},{"id":"https://openalex.org/keywords/fondaparinux","display_name":"fondaparinux","score":0.996999979019165},{"id":"https://openalex.org/keywords/clopidogrel","display_name":"clopidogrel","score":0.6919999718666077},{"id":"https://openalex.org/keywords/prasugrel","display_name":"prasugrel","score":0.9300000071525574},{"id":"https://openalex.org/keywords/cangrelor","display_name":"cangrelor","score":0.7549999952316284},{"id":"https://openalex.org/keywords/tissue-factor-pathway-inhibitor","display_name":"tissue factor pathway inhibitor","score":0.6359999775886536},{"id":"https://openalex.org/keywords/recombinant-activated-protein-c","display_name":"recombinant activated protein C","score":0.8349999785423279},{"id":"https://openalex.org/keywords/thrombomodulin","display_name":"thrombomodulin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/antithrombin-iii","display_name":"antithrombin III","score":0.8849999904632568}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8804904222488403},{"id":"https://openalex.org/C2779630707","wikidata":"https://www.wikidata.org/wiki/Q3570984","display_name":"Ximelagatran","level":5,"score":0.7105294466018677},{"id":"https://openalex.org/C2776708134","wikidata":"https://www.wikidata.org/wiki/Q3655338","display_name":"Cangrelor","level":5,"score":0.6314789056777954},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5666188597679138},{"id":"https://openalex.org/C57002609","wikidata":"https://www.wikidata.org/wiki/Q5281999","display_name":"Discovery and development of direct thrombin inhibitors","level":4,"score":0.5349048376083374},{"id":"https://openalex.org/C2776301958","wikidata":"https://www.wikidata.org/wiki/Q407431","display_name":"Warfarin","level":3,"score":0.5235228538513184},{"id":"https://openalex.org/C2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","level":5,"score":0.5176406502723694},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5056211948394775},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.4707986116409302},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.4555361270904541},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36933088302612305},{"id":"https://openalex.org/C2777849778","wikidata":"https://www.wikidata.org/wiki/Q410237","display_name":"Clopidogrel","level":3,"score":0.33683979511260986},{"id":"https://openalex.org/C2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","level":4,"score":0.3257264494895935},{"id":"https://openalex.org/C2780890252","wikidata":"https://www.wikidata.org/wiki/Q420542","display_name":"Ticagrelor","level":4,"score":0.3174343407154083},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.24783965945243835},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1779722273349762},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.17714998126029968},{"id":"https://openalex.org/C2778810321","wikidata":"https://www.wikidata.org/wiki/Q419345","display_name":"Dabigatran","level":4,"score":0.16050118207931519},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15752261877059937},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.13206517696380615},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.1178816556930542}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001777","descriptor_name":"Blood Coagulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006493","descriptor_name":"Heparin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006495","descriptor_name":"Heparin, Low-Molecular-Weight","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011516","descriptor_name":"Prothrombin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013917","descriptor_name":"Thrombin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015906","descriptor_name":"Angioplasty, Balloon, Coronary","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065427","descriptor_name":"Factor Xa Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18506123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18506123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International angiology : a journal of the International Union of Angiology","raw_type":"Journal Article"},{"id":"pmh:oai:acikerisim.trakya.edu.tr:20.500.14551/17093","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/20.500.14551/17093","pdf_url":null,"source":{"id":"https://openalex.org/S4306401406","display_name":"Trakya University's Institutional Open Access System (Trakya University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I12387023","host_organization_name":"Trakya University","host_organization_lineage":["https://openalex.org/I12387023"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Review Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7220814447","https://openalex.org/W2620361063","https://openalex.org/W2020165588","https://openalex.org/W2081957280","https://openalex.org/W2430296439","https://openalex.org/W2062232878","https://openalex.org/W4250946806","https://openalex.org/W1511115228","https://openalex.org/W2113256644","https://openalex.org/W2077238944"],"abstract_inverted_index":{"The":[0,32,83,130,146,265,302,317,379],"conventional":[1,396],"management":[2,77,126,313,414],"of":[3,13,34,43,49,59,67,78,127,133,140,159,194,287,292,314,370,389,415],"thrombotic":[4,79,128,144,315,416],"and":[5,17,30,40,80,95,102,119,165,175,198,212,221,235,250,323,328,342,350,382,403,417],"cardiovascular":[6,81,418],"disorders":[7,419],"is":[8,187],"based":[9],"on":[10,191],"the":[11,22,41,65,72,76,123,138,192,209,247,256,288,312,395,413],"use":[12,48,132,220],"heparin,":[14],"oral":[15,206,219],"anticoagulants":[16],"aspirin.":[18,114],"Despite":[19],"progress":[20],"in":[21,75,106,122,311,398,412],"sciences,":[23],"these":[24,60,134,245,390],"drugs":[25,52,61,86,135,305,384,397],"still":[26,70,136],"remain":[27],"a":[28,46,117,188,308,338,368,371,409],"challenge":[29],"mystery.":[31],"development":[33,193],"low":[35],"molecular":[36],"weight":[37],"heparins":[38],"(LMWHS)":[39],"synthesis":[42],"heparinomimetics":[44],"represent":[45,345],"refined":[47],"heparin.":[50,68],"Additional":[51],"will":[53,62,298,405],"continue":[54,406],"to":[55,142,204,231,377,393,407,422],"develop.":[56],"However,":[57,227],"none":[58,388],"ever":[63],"match":[64],"polypharmacology":[66],"Aspirin":[69],"remains":[71,137],"leading":[73],"drug":[74,335],"disorders.":[82,129,145,316],"newer":[84,303,346,380],"antiplatelet":[85,304,383],"such":[87,150],"as":[88,151,331],"adenosine":[89],"diphosphate":[90],"receptor":[91],"inhibitors,":[92,355],"GPIIb/IIIa":[93],"inhibitors":[94,98,180],"other":[96],"specific":[97,177],"have":[99,103,109,182,215,222,238,306,325,366],"limited":[100],"effects":[101,291],"been":[104,111,184,216,239],"tested":[105],"patients":[107],"who":[108],"already":[110],"treated":[112],"with":[113,241,321,374],"Warfarin":[115],"provides":[116],"convenient":[118],"affordable":[120],"approach":[121,139],"long-term":[124],"outpatient":[125],"optimized":[131],"choice":[141],"manage":[143],"new":[147,309,334],"anticoagulant":[148,381],"targets,":[149],"tissue":[152,166],"factor,":[153],"individual":[154],"clotting":[155],"factors,":[156],"recombinant":[157,170],"forms":[158],"serpins":[160],"(antithrombin,":[161],"heparin":[162],"co-factor":[163],"II":[164],"factor":[167],"pathway":[168],"inhibitors),":[169],"activated":[171],"protein":[172],"C,":[173],"thrombomodulin":[174],"site":[176],"serine":[178],"proteases":[179],"complexes":[181],"also":[183,275],"developed.":[185],"There":[186],"major":[189,277,410],"thrust":[190],"orally":[195,257],"bioavailable":[196],"anti-Xa":[197],"IIa":[199],"agents,":[200],"which":[201],"are":[202,353,385,391],"slated":[203],"replace":[205,394],"anticoagulants.":[207],"Both":[208],"anti-factor":[210],"Xa":[211],"anti-IIa":[213],"agents":[214],"developed":[217],"for":[218,262,333,420],"provided":[223],"impressive":[224],"clinical":[225,271,319,372],"results.":[226],"safety":[228],"concerns":[229],"related":[230],"liver":[232],"enzyme":[233],"elevations":[234],"thrombosis":[236],"rebound":[237],"reported":[240],"their":[242],"use.":[243],"For":[244],"reasons,":[246],"US":[248],"Food":[249],"Drug":[251],"Administration":[252],"did":[253],"not":[254],"approve":[255],"active":[258],"antithrombin":[259],"agent":[260],"Ximelagatran":[261],"several":[263],"indications.":[264],"synthetic":[266],"pentasaccharide":[267],"(Fondaparinux)":[268],"has":[269],"undergone":[270],"development.":[272,336],"Unexpectedly,":[273],"Fondaparinux":[274,283],"produced":[276],"bleeding":[278],"problems":[279],"at":[280],"minimal":[281],"dosages.":[282],"represents":[284],"only":[285],"one":[286],"multiple":[289],"pharmacologic":[290],"heparins.":[293],"Thus,":[294],"its":[295],"therapeutic":[296],"index":[297],"be":[299],"proportionately":[300],"narrower.":[301],"added":[307],"dimension":[310],"favorable":[318],"outcomes":[320],"aspirin":[322,404],"clopidogrel":[324],"validated":[326],"COX-1":[327],"P2Y12":[329,347],"receptors":[330],"targets":[332],"Prasugrel,":[337],"novel":[339],"thienopyridine,":[340],"Cangrelor":[341,349],"AZD":[343,351],"6140":[344,352],"antagonists.":[348],"direct":[354],"whereas":[356],"Prasugrel":[357,375],"requires":[358],"metabolic":[359],"activation.":[360],"While":[361],"clinically":[362],"effective,":[363],"recent":[364],"results":[365],"prompted":[367],"closure":[369],"trial":[373],"due":[376],"bleeding.":[378],"attractive,":[386],"however,":[387],"expected":[392],"polytherapeutic":[399],"approaches.":[400],"Heparins,":[401],"warfarin":[402],"play":[408],"role":[411],"years":[421],"come.":[423]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}